Silence Therapeutics plc
SLNCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $364,918 | $131,246 | $259,498 | $469,899 |
| - Cash | $121,330 | $54,031 | $66,338 | $99,248 |
| + Debt | $117 | $272 | $446 | $137 |
| Enterprise Value | $243,705 | $77,487 | $193,605 | $370,788 |
| Revenue | $43,258 | $25,375 | $17,501 | $12,415 |
| % Growth | 70.5% | 45% | 41% | – |
| Gross Profit | $31,448 | $15,057 | $8,192 | $4,959 |
| % Margin | 72.7% | 59.3% | 46.8% | 39.9% |
| EBITDA | -$48,989 | -$49,778 | -$50,624 | -$45,421 |
| % Margin | -113.2% | -196.2% | -289.3% | -365.9% |
| Net Income | -$45,309 | -$43,267 | -$40,489 | -$39,410 |
| % Margin | -104.7% | -170.5% | -231.4% | -317.4% |
| EPS Diluted | -0.33 | -0.49 | -0.52 | -0.44 |
| % Growth | 32.7% | 5.8% | -18.2% | – |
| Operating Cash Flow | -$67,640 | -$39,350 | -$45,456 | $6,806 |
| Capital Expenditures | -$211 | -$56 | -$440 | -$1,334 |
| Free Cash Flow | -$67,851 | -$39,395 | -$45,896 | $5,472 |